Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ThreeD Capital Inc. Capital/Financing Update 2021

Feb 19, 2021

43283_rns_2021-02-18_1c481ab1-0e7f-4d1e-badd-e6fb85ebbbc8.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [118 x 72] intentionally omitted <==

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S.

ThreeD Capital Inc. Announces Extension of Warrant Terms

Toronto – February 18, 2021 – ThreeD Capital Inc. (the “Company” or “ThreeD”) (CSE:IDK) (OTCQB:IDKFF) announces that it is extending the term of certain of its existing share purchase warrants of the Company, as follows (collectively, the “ Warrants ”):

Date of Issuance Number of Warrants Original Expiry Date New Expiry Date
April 13,2018 1,066,661 April 13,2021 April 13,2022
August 23,2018 1,101,662 August 23,2021 August 23,2022
October 30,2018 904,164 October 30,2021 October 30,2022

Each Warrant is currently exercisable at $1.80, which will remain unchanged. The extension of the respective expiry dates of the Warrants has been approved by the board of directors of the Company.

About ThreeD Capital Inc.

ThreeD is a publicly‐traded Canadian‐based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.

For further information: Jakson Inwentash [email protected] Phone: 416‐941‐8900 ext 107

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

130 Spadina Avenue, Suite 401, Toronto, Ontario M5V 2L4, Tel/Fax: (416) 941-8900